Florida Issues Emergency Schedule I Ban on Ultra-Potent 7-OH Kratom Extracts Linked to Hundreds of Overdose Deaths
Key Insights
Florida Attorney General James Uthmeier signed an emergency rule placing highly concentrated 7-hydroxymitragynine (search) (7-OH) and related compounds into Schedule I, enabling felony arrests and product seizures.
Florida medical examiners have linked at least 587 overdose deaths to these products since 2013, with Poison Control data showing more than 25% of exposed patients requiring ICU treatment.
The emergency regulations cap restricted chemicals at 1 milligram per gram of solid or per milliliter of liquid, and require any 7-OH product to contain at least 100 times more mitragynine by mass.
Florida state authorities have enacted an immediate emergency rule to control highly concentrated versions of 7-hydroxymitragynine (search) (7-OH) and several related chemical products sold across the state. Attorney General James Uthmeier signed the order placing these substances into Schedule I — a designation reserved for compounds with a high risk of abuse and no accepted medical use — empowering law enforcement to execute felony arrests, product seizures, and manufacturing shutdowns.
"Today I signed an emergency rule because these dangerous concentrated 7-OH products present an imminent hazard to the public safety of Floridians — especially our children and teens," Uthmeier said. "By expanding the rule to include new 7-OH-related compounds to Schedule I, we are removing these addictive poisons from store shelves, protecting families, and holding manufacturers and sellers accountable."
Chemical Origins and Market Presence
While 7-OH occurs naturally in the kratom plant in trace amounts between 0.01% and 0.04%, manufacturers have isolated and concentrated the chemical into high-potency formulas. These products are sold online, in vape shops, and at convenience stores under brand names including Hydroxy, 7Tabz, and 7OHMZ, frequently employing appealing flavors and mislabeling tactics to evade detection.
The full list of chemical compounds covered under the new Schedule I placement includes 7-hydroxymitragynine (search), mitragynine pseudoindoxyl (search), 7-acetoxymitragynine (search), 9-hydroxycorynantheidine, 10-hydroxycorynantheidine, MGM-15, and MGM-16.
Clinical Impact and Overdose Burden
Data from medical authorities highlights a steep rise in exposure and physical harm linked to these concentrated extracts. The chemicals act powerfully on the brain's opioid receptors (search), causing rapid addiction, severe withdrawal symptoms, and dose-dependent respiratory depression. Florida medical examiners have linked at least 587 overdose deaths to these products since 2013. Recent Poison Control records show hundreds of cases across the state, with more than 25% of those patients requiring intensive care unit treatment.
Dr. Cory Howard, an emergency medicine physician and medical toxicologist at Tampa General Hospital, described the broad demographic impact. "Exposure and overdose involving 7-OH mitragynine has been on the rise in recent years," Howard said. "We are seeing this affect Floridians of all ages, from infants to the elderly, which speaks directly to how aggressively and irresponsibly this drug is marketed."
Dr. Thomas Nappe, an addiction medicine specialist and toxicologist with the Florida Poison Information Center – Tampa, emphasized the drug's severe dependency profile. "I have personally witnessed the harm caused by 7-OH mitragynine, a dangerous opioid-like substance that causes severe dependence and withdrawal, requiring intense support to foster recovery," Nappe said. "Prevention is key."
Emergency Department Perspectives
Hospital executives report that the ease of purchasing these products contributes to accidental overdoses, as consumers are often unaware of the strength of the extracts they purchase. Melissa Golombek, Executive Vice President of the Florida Health Sciences Center and President of Tampa General Hospital, explained the pattern observed in emergency departments.
"At Tampa General Hospital, we see firsthand the devastating consequences of dangerous substances like 7-OH," Golombek said. "Too often, patients who have purchased these products at a nearby convenience store, unaware of how addictive and lethal they can be, arrive in our emergency department after an overdose."
Regulatory Framework and Enforcement
The newly implemented emergency regulations establish strict technical boundaries to prevent suppliers from distributing altered or super-concentrated formulas. No product sold may contain more than 1 milligram of the restricted chemicals per gram of solid material or per milliliter of liquid. Additionally, any product containing 7-OH must feature at least 100 times more regular mitragynine by mass — a requirement designed to block synthetic manipulation.
The emergency action builds on ongoing enforcement efforts by the Florida Department of Agriculture and Consumer Services (search) (FDACS). Florida Commissioner of Agriculture Wilton Simpson stated that his agency has worked continuously to restrict retail access to these substances.
"Last year, Florida took decisive action to help defend Floridians from dangerous, highly addictive 7-OH products," Simpson said. "Since our emergency rule took effect, FDACS has removed over 23,000 illegal 7-OH packages from retailers across Florida, and our inspectors continue to conduct routine checks and targeted sweeps across our state."
Public Health Leadership
State Surgeon General Dr. Joseph A. Ladapo underscored the pharmacological threat. "7-OH poses a serious threat to public health," Ladapo said. "These highly concentrated products act on opioid receptors (search) and have been linked to addiction, overdose, and seizures."
Florida State Representative Dean Black reinforced that the legislative and executive branches prioritized public safety over commercial interests. "By today's actions, we make it clear that public safety comes first," Black said. "Special interests do not matter in this discussion. People's lives are the only special interest we should care about."
National Context and Penalties
Florida joins several other states that have enacted restrictions on these specific compounds. Prior to these state-level actions, the Trump administration issued warnings regarding the high potency of these novel opioids and recommended that the federal Drug Enforcement Administration place them on its official schedules. Following the implementation of this emergency rule, individuals found violating the manufacturing or distribution restrictions in Florida face serious criminal charges, with potential penalties carrying up to 30 years in prison.